0000950170-24-099253.txt : 20240820 0000950170-24-099253.hdr.sgml : 20240820 20240820175938 ACCESSION NUMBER: 0000950170-24-099253 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240816 FILED AS OF DATE: 20240820 DATE AS OF CHANGE: 20240820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TRV GP IV, LLC CENTRAL INDEX KEY: 0001688325 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39485 FILM NUMBER: 241226547 BUSINESS ADDRESS: STREET 1: 201 BROOKLINE AVE, SUITE 1401 CITY: BOSTON STATE: MA ZIP: 02215 BUSINESS PHONE: 617-585-2000 MAIL ADDRESS: STREET 1: 201 BROOKLINE AVE, SUITE 1401 CITY: BOSTON STATE: MA ZIP: 02215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Third Rock Ventures GP IV, L.P. CENTRAL INDEX KEY: 0001688326 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39485 FILM NUMBER: 241226548 BUSINESS ADDRESS: STREET 1: 29 NEWBURY STREET, 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-585-2000 MAIL ADDRESS: STREET 1: 29 NEWBURY STREET, 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Third Rock Ventures IV, L.P. CENTRAL INDEX KEY: 0001688327 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39485 FILM NUMBER: 241226549 BUSINESS ADDRESS: STREET 1: 29 NEWBURY STREET, 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-585-2000 MAIL ADDRESS: STREET 1: 29 NEWBURY STREET, 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tango Therapeutics, Inc. CENTRAL INDEX KEY: 0001819133 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 BROOKLINE AVENUE STREET 2: SUITE 901 CITY: BOSTON STATE: MA ZIP: 02215 BUSINESS PHONE: (857) 320-4900 MAIL ADDRESS: STREET 1: 201 BROOKLINE AVENUE STREET 2: SUITE 901 CITY: BOSTON STATE: MA ZIP: 02215 FORMER COMPANY: FORMER CONFORMED NAME: BCTG Acquisition Corp. DATE OF NAME CHANGE: 20200723 4 1 ownership.xml 4 X0508 4 2024-08-16 0001819133 Tango Therapeutics, Inc. TNGX 0001688327 Third Rock Ventures IV, L.P. C/O THIRD ROCK VENTURES, LLC 201 BROOKLINE AVE, SUITE 1401 BOSTON MA 02215 false false true false 0001688326 Third Rock Ventures GP IV, L.P. 201 BROOKLINE AVE, SUITE 1401 BOSTON MA 02215 false false true false 0001688325 TRV GP IV, LLC 201 BROOKLINE AVE, SUITE 1401 BOSTON MA 02215 false false true false false Common Stock 2024-08-16 4 S false 135000 9.7885 D 17351475 D Common Stock 2024-08-19 4 S false 150000 10.0928 D 17201475 D The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $9.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). These shares are directly held by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $10.475, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3). /s/ Kevin Gillis, Chief Operating Officer of TRV GP IV, LLC, general partner of Third Rock Ventures GP IV, L.P., general partner of Third Rock Ventures IV, L.P. 2024-08-20 /s/ Kevin Gillis, Chief Operating Officer of TRV GP IV, LLC, general partner of Third Rock Ventures GP IV, L.P. 2024-08-20 /s/ Kevin Gillis, Chief Operating Officer of TRV GP IV, LLC 2024-08-20